ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "IL-1"

  • Abstract Number: 1120 • 2016 ACR/ARHP Annual Meeting

    Interleukin-1β Stabilize CXCL2 mRNA and Increase Its Expression

    Satoshi Yamasaki, Yusuke Yoshida and Eiji Sugiyama, Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

    Background/Purpose: Changes in gene expression are closely related to inflammation and joint destruction in RA. Recently, it has been recognized that post-transcriptional regulation of the…
  • Abstract Number: 318 • 2015 ACR/ARHP Annual Meeting

    Dual Variable Domain-Immunoglobulin (Dvd-Ig™) Abt-981 Simultaneously and Dose-Dependently Inhibits Interleukin-1 Αlpha and -1 Βeta in Subjects with Knee Osteoarthritis

    Susanne X. Wang1, Ralf Loebbert2, Erik Sampson3, Mary Saltarelli1, Jeroen Medema1 and Feng Hong3, 1AbbVie Inc., North Chicago, IL, 2AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, 3AbbVie Inc., Worcester, MA

    Background/Purpose: ABT-981 is a novel human Dual-Variable Domain Immunoglobulin (DVD-Ig™) that inhibits interleukin (IL)-1α and IL-1β. The purpose of this study is to evaluate IL-1α…
  • Abstract Number: 319 • 2015 ACR/ARHP Annual Meeting

    Phase 1 Studies of Anti-Interleukin-1 Dual-Variable Domain Immunoglobulin in Healthy Subjects and Patients with Osteoarthritis

    Susanne X. Wang1, Wei Liu1, Ping Jiang1, Martin Okun1, Richard Preston2, Carlos J. Lozada2, David Carter1 and Jeroen Medema1, 1AbbVie Inc., North Chicago, IL, 2University of Miami Miller School of Medicine, Miami, FL

    Background/Purpose: Interleukin (IL)-1 is a catabolic cytokine that plays an important role in pathogenesis and progression of osteoarthritis (OA). Two phase 1 clinical trials investigated…
  • Abstract Number: 935 • 2015 ACR/ARHP Annual Meeting

    Microrna-146a Provides Feedback Regulation of Monosodium Urate-Induced Gouty Arthritis in Mice By Targeting Tumor Necrosis Factor Receptor Associated Factor 6 and Interleukin-1 Receptor-Associated Kinase 1

    Quan-Bo Zhang1,2, Jing-Guo Zhou3, Cong-Cong Yin1, Yu-Feng Qing4, Chang-Gui Li5, Li Zhou1 and Qing-Sheng Mi6, 1Immunology Program, Department of Dermatology, Henry Ford Health System, Detroit, MI, 2Geriatrics, Affliated hospital of North Sichuan Medical College, Nanchong, China, 3Department of Rheumatology and Immunology, Affliated hospital of North Sichuan Medical College, Nanchong, China, 4Affiliated Hospital of North Sichuan Medical College, Sichuan 637000, China, Nanchong, China, 5Affiliated Hospital of Qingdao University, Qingdao, China, 6Immunology, Dermatology, Henry Ford Health System, Detroit, MI

    Background/Purpose: MicroRNAs (miRNAs) have been shown to serve as important regulators for inflammatory and immune responses and are implicated in several immune disorders including gouty…
  • Abstract Number: 938 • 2015 ACR/ARHP Annual Meeting

    Long-Term Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF Receptor-Associated Periodic Syndrome

    Marco Gattorno1, Marco Cattalini2, L. Obici3, Roberto Barcellona4, Antonio Speziale5, Yolandi Joubert5, Guido Junge5 and Helen Lachmann6, 1Pediatric Rheumatology, G. Gaslini Institute, Genova, Italy, 2Pediatric Clinic, University of Brescia, Brescia, Italy, 3Amyloid Centre, Policlinico S. Matteo, Pavia, Italy, 4Hospital of Sciacca, Sciacca, Italy, 5Novartis Pharma AG, Basel, Switzerland, 6UK National Amyloidosis Centre, University College London Medical School, London, United Kingdom

    Background/Purpose: Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) is a rare, dominantly inherited periodic fever syndrome characterized by recurrent attacks of fever associated with…
  • Abstract Number: 939 • 2015 ACR/ARHP Annual Meeting

    Long-Term Efficacy and Safety of Canakinumab in Active Hyperimmunoglobulinemia D with Periodic Fever Syndrome

    Juan Ignacio Arostegui1, Jordi Anton2, Inmaculada Calvo-Penedes3, Angel Robles4, Antonio Speziale5, Yolandi Joubert5, Guido Junge5 and Jordi Yagüe6, 1Department of Immunology-CDB, Hospital Clínic, Barcelona, Spain, 2Unitat de Reumatologia Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain, 3Hospital de La Fe, Valencia, Spain, 4Hospital La Paz, Madrid, Spain, 5Novartis Pharma AG, Basel, Switzerland, 6Immunology Department, Hospital Clinic Barcelona, Barcelona, Spain

    Background/Purpose: Hyperimmunoglobulinemia D with periodic fever syndrome (HIDS) is a recessively inherited disorder characterized by periodic episodes of high fever, abdominal distress, joint pain, and…
  • Abstract Number: 1136 • 2015 ACR/ARHP Annual Meeting

    IL-1β-Induced Stress Granules Sequester COX-2 mRNA and Regulates Its Expression in Human OA Chondrocytes

    Mohammad Ansari1 and Tariq Haqqi2, 1Anatomy & Neurobiology, Northeast Ohio Medical University, Roostown, OH, 2Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH

    Background/Purpose: Stress granules (SGs) are ribonucleoprotein complexes assembled in the cytoplasm of eukaryotic cells to respond adequately to stress (e.g. heat shock, UV irradiation, oxidative…
  • Abstract Number: 1164 • 2015 ACR/ARHP Annual Meeting

    Four Types of Calcium Pyrophosphate Crystals Differentially Induce IL-1beta Production By Monocytes through ATP/Potassium Efflux/ROS Dependent Pathways

    Laure Campillo-Gimenez1, Pierre Gras2, Félix Renaudin3, Marion Renaud3, Lorène Télot4, Amine Mellouk5, Pierre Bobé5, Jean-Michel Camadro4, Christèle Combes2, Martine Cohen-Solal3,6, Frederic Liote3,6 and Hang-Korng Ea3,6, 1Hôpital Lariboisière, Centre Viggo Petersen, INSERM UMR1132, Paris Diderot University, Paris, France, 2ENSIACET, CIRIMAT, INPT-UPS-CNRS, Toulouse, France, 3INSERM UMR1132, Paris Diderot University, Paris, France, 4CNRS UMR7592, Jacques Monod Institute, Paris Diderot University, Paris, France, 5INSERM UMRS757, Paris Sud University, Orsay, France, 6AP-HP, Lariboisière Hospital, Rheumatology Department, Paris, France

    Background/Purpose: Monoclinic and triclinic calcium pyrophosphate (m- and t-CPP) crystals are the 2 types of CPP crystals observed in human joints. Frequently asymptomatic, it can…
  • Abstract Number: 1246 • 2015 ACR/ARHP Annual Meeting

    Gene Expression Analysis of Adult Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis Suggest a Single Disease Continuum

    N. Nirmala1, Arndt Brachat2, Eugen Feist3, Norbert Blank4, Christof Specker5, Matthias Witt6, Jan Zernicke7, Alberto Martini8 and Guido Junge9, 1Novartis Institutes for Biomedical Research, Cambridge, MI, 2Novartis Institutes for Biomedical Research, Basel, Switzerland, 3Rheumatology and Clinical Immunology, Charite University Hospital, Berlin, Germany, 4University of Heidelberg, Heidelberg, Germany, 5Kliniken Essen Süd, Essen, Germany, 6Division for Rheumatology, University of Munich, Munich, Germany, 7Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 8Department of Pediatrics, G Gaslini Institute, Genova, Italy, 9Novartis Pharma AG, Basel, Switzerland

    Background/Purpose: Adult-onset Still's disease (AOSD) is a rare auto-inflammatory disorder.1 The superimposable systemic clinical features of AOSD and the pediatric syndrome known as systemic juvenile…
  • Abstract Number: 1364 • 2015 ACR/ARHP Annual Meeting

    Treating Experimental Arthritis with the Innate Immune Inhibitor IL-37 Reduces Joint and Systemic Inflammation

    Giulio Cavalli1, Marije Koenders2, Lorenzo Dagna3, Alberto Mantovani4, Cecilia Garlanda4, Leo Joosten5 and Charles Dinarello1, 1Department of Medicine, Division of Infectious Diseases, University of Colorado, Denver, CO, 2Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 3Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milano, Italy, 4Research Institute Humanitas, Milan, Italy, 5Internal Medicine, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: Characterized as a fundamental inhibitor of innate inflammation, IL‑1 family member IL‑37 is expressed in the synovia of patients with rheumatoid arthritis. We investigated…
  • Abstract Number: 2346 • 2015 ACR/ARHP Annual Meeting

    Rebamipide Suppresses Monosodium Urate Crystal-Induced Interleukin-1b Production through Regulation of Oxidative Stress and Caspase-1 in THP-1 Cells

    Jung-Yoon Choe1, Minyoung Her2 and Seong-Kyu Kim3, 1Division of Rheumatology, Daegu Catholic University Medical Center, Daegu, South Korea, 2Busan Paik Hospital, Inje University, Busan, South Korea, 3Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea

    Background/Purpose: This study investigated the effect of rebamipide on activation of NLRP3 inflammasome and reactive oxygen species (ROS) in monosodium urate (MSU) crystal-induced interleukin-1b (IL-1b)…
  • Abstract Number: 3224 • 2015 ACR/ARHP Annual Meeting

    Salivary IL-1 Alpha and IL-1 Beta Levels Are Associated with Oral Mucosal Activity in Behcet’s Disease

    Nilufer Alpay Kanitez1, Bahtiyar Toz1, Feyza Berktas1, Sertan Ergun2, Meltem Koray2, Nuray Gurel Polat3, Burak Erer1 and Ahmet Gül1, 1Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Oral Medicine, Istanbul University, Faculty of Dentistry, Istanbul, Turkey, 3Department of Microbiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: Recurrent oral aphthous ulcers are the common manifestation of the Behçet's disease (BD), and they are indistinguishable from ulcers of recurrent aphthous stomatitis (RAS).…
  • Abstract Number: 14 • 2015 ACR/ARHP Annual Meeting

    The SLE Susceptibility Gene Macrophage Migration Inhibitory Factor Serves As an Upstream Regulator of NLRP3 (NOD-like receptor family pyrin domain containing 3) Expression and Subsequent IL-1beta Production in Human Monocytes in Response to Lupus U1-snRNP Immune Complex

    Min Sun Shin1, Youna Kang1, Elizabeth Wahl1, Lin Leng1, Richard Bucala1 and Insoo Kang2, 1Yale University School of Medicine, New Haven, CT, 2Rheumatology Section, Yale University School of Medicine, New Haven, CT

    Background/Purpose: The pathologic hallmarks of systemic lupus erythematosus (SLE or lupus) are altered immune responses to nuclear autoantigens with autoantibody production and subsequent tissue injury.…
  • Abstract Number: 18 • 2015 ACR/ARHP Annual Meeting

    Epigallocatechin-3-Gallate (EGCG) Facilitates TAK1 Nuclear Translocation and Its Interaction with p300 to Inhibit Histone Acetylation in Human RA Synovial Fibroblasts

    Anil Singh1,2, Mukesh Chourasia3 and Salahuddin Ahmed4, 1Department of Pharmaceutical Science, Washington State University, Spokane, WA, 2Department of Pharmaceutical Sciences, Washington State University, Spokane, WA, 3Department of Pharmacoinformatics,, National lnstitute of Pharmaceutical Education and Research, Hajipur,, India, 4Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA

    Background/Purpose: TAK1 is one of the most important proteins in IL-1β signaling cascade that mediates downstream p38/JNK and NF-κB activation. In the present study, we…
  • Abstract Number: 19 • 2015 ACR/ARHP Annual Meeting

    Pentagalloyl Glucose (PGG) Exhibits Anti-Rheumatic Activity in Human RA Synovial Fibroblasts and Rat Adjuvant-Induced Arthritis

    Sadiq Umar1, Gates Roe1, Sabrina Fechtner1 and Salahuddin Ahmed2, 1Department of Pharmaceutical Science, Washington State University College of Pharmacy, Spokane, WA, 2Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA

    Background/Purpose: Pentagalloyl glucose (PGG) is a natural polyphenolic and water-soluble gallotannin that exhibits anti-cancer and anti-inflammatory activities. In the present study, we evaluated the efficacy…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology